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Abstract
Background: Chondrogenesis is the complex process that leads to the establishment of cartilage and bone formation. Due
to their ability to differentiate in vitro and mimic development, embryonic stem cells (ESCs) show great potential for
investigating developmental processes. In this study, we used chondrogenic differentiation of ESCs as a model to analyze
morphogenetic events during chondrogenesis.
Methodology/Principal Findings: ESCs were differentiated into the chondrocyte lineage, forming small cartilaginous
aggregates in suspension. Differentiated ESCs showed that chondrogenesis was typically characterized by five overlapping
stages. During the first stage, cell condensation and aggregate formation was observed. The second stage was
characterized by differentiation into chondrocytes and fibril scaffold formation within spherical aggregates. Deposition of
cartilaginous extracellular matrix and cartilage formation were hallmarks of the third stage. Apoptosis of chondrocytes,
hypertrophy and/or degradation of cartilage occurred during the fourth stage. Finally, during the fifth stage, bone
replacement with membranous calcified tissues took place.
Conclusions/Significance: We demonstrate that ESCs show the chondrogenic differentiation pathway from the pluripotent
stem cell to terminal skeletogenesis through these five stages in vitro. During each stage, morphological changes acquired
in preceding stages played an important role in further development as a scaffold or template in subsequent stages. The
study of chondrogenesis via ESC differentiation may be informative to our further understanding of skeletal growth and
regeneration.
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Introduction
Cartilage is the first skeletal tissue to be formed during
embryogenesis and participates in endochondral or perichondral
ossification within developing, growing and regenerating bones
[1]. During skeletal development, chondrogenesis and subsequent
bone formation is a multi-step process that is tightly regulated by
dynamic morphogenetic events and phenotypic changes [2].
During chondrogenesis, chondrocytes proliferate, maturate and
ultimately undergo hypertrophy and apoptosis [1,2]. A better
understanding of the natural developmental process of chondro-
genesis would help to create more efficient cartilage and bone
therapeutic modalities.
Many efforts have been explored for understanding the
morphogenetic event of chondrogenesis in normal individuals
[1]. Due to their ability to differentiate into all cell types in the
body, embryonic stem cells (ESCs) show great potential for
investigating and understanding the developmental processes that
occur during organogenesis, including cartilage and bone
formation [3]. Therefore, we hypothesized that an ESC
differentiation model system would offer the possibility of following
this multi-step process from progenitor cells to terminal develop-
ment. The differentiation of ESCs would provide an attractive
model for further understanding skeletal development and
regeneration.
We and others have previously explored ESC chondrogenesis in
vitro [3–8]. Although the cellular events were described well in
these studies, they had not examined the multi-step process of
morphogenetic events and phenotypic changes using the ESC-
derived cartilaginous aggregates by histomorphometry and
immnohistochemistry in detail. In addition, even though endo-
chondral ossification surrounding the connective tissue was shown
in vivo, in vitro bone replacement through cartilage degradation
without vasculogenesis remained unclear [9,10].
In this study, based on our previous report of the direct
chondrogenic differentiation of ESCs via the micro-mass culture
approach, we examined the long-term expansion of cartilaginous
aggregates in static suspension culture. Here, we demonstrate the
multi-step developmental processes of chondrogenesis and subse-
quent bone replacement in vitro. Accordingly, we define the five
main stages of chondrogenesis by the cellular, extracellular and
molecular changes occurring in ESC chondrogenic differentiation.
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ESC chondrogenic differentiation
Mouse D3 ESCs (American Type Culture Collection, Rockville,
Maryland, USA) were differentiated into the chondrocyte lineage
using micro-mass culture.DissociatedESCs werecultured ata high-
density, 1.0610
5 cells per 10 ml69 spots in 6 cm culture dish for
2 hours [8,11]. After incubation, medium was added to each dish
without dissociating the cell drops. For chondrocyte differentiation,
we used differentiation media containing DMEM (Gibco), 1% non-
essentialaminoacids(Invitrogen),50 U/mlpenicillinand50 mg/ml
streptomycin (Invitrogen), 0.1 mM 2-mercaptoethanol (Invitrogen),
1% ITS (Invitrogen), 1% FBS (Gibco), 10 ng/ml TGF-b1
(PeproTech), 10 ng/ml BMP-2 (PeproTech), and 50 mg/ml
Ascorbic acid (Sigma). Medium was changed every 2 days.
Differentiated ESCs formed aggregates (Fig. 1Aa). After 5 days,
these aggregates were separated from the dishes by pipetting and
transferred to suspension culture in 6 cm petri dishes containing
differentiation media containing DMEM, 1% non-essential amino
acids, penicillin streptomycin, 0.1 mM 2-mercaptoethanol, 1%
ITS, 1% FBS, 10 ng/ml BMP-2 and 50 mg/ml Ascorbic acid.
Scanning electron microscopy
Aggregates were sampled at day 15 and 40. These specimens
were fixed in 2.5% gluteraldehyde (Sigma) in 1M Sodium
Cacodylate buffer (Sigma) for 1 hour. After washing with Sodium
Cacodylate buffer, samples were fixed by 2% Osmium (Electron
Microscopy Sciences) for 15 min. The samples were dehydrated in
increasing percentages of anhydrous ethyl alcohol (50%, 75%, 90%
and 100%). The samples were dried using increasing percentages of
Hexamethyl disilazine (HMDS, Sigma) diluted in anhydrous ethyl
alcohol(10%, 30%, 50%, 70%, 80%, 90% and 100%). After air
drying overnight, aggregates were coated with gold using a
Hummer 1 Sputter Coater. The samples were examined by SEM
(Phillips/FEI ESEM XL-30) operated at working distance of 5.2–
10.7 mm and an accelerating voltage of 20 kV [11].
GAG assay
To determine the total glycosaminoglycan (GAG) from one
micro-mass containing 20–30 aggregates samples were taken at
day 15 and 30 of differentiation. The cultures were digested with
100 ml of papain digestion buffer (4.5 unit/ml in 50mM Phosphate
buffer, pH6.5, with 2mM N-acetylcysteine and 2mM Na2EDTA,
Sigma) for 4 hours at 65uC. Values are calculated from a standard
curve using Chondroitin Sulfate-A Sodium Salt (Sigma), which
was measured along with the samples at 510 nm in a Benchmark
Plus microplate spectrophotometer (BioRad) [8].
Calcium Assay
To measure calcium accumulation from one micro-mass contain-
ing 20–30 aggregates samples were taken at day 15 and 30 of
differentiation. The cultures were digested with 100 ml of 10% formic
acid for 4 hours room temperature. Values were calculated from a
standard curve using Arsenazo III (DCL), which was measured along
with the samples at 650 nm in a Benchmark Plus microplate
spectrophotometer according to the manufacturer’s instructions [8].
RNA isolation and semi-quantitative and quantitative RT-
PCR
Total RNA was isolated from cell culture at day 0, 10, 15, 20, 30,
40, 50 and 60 of differentiation using the RNeasy Mini Kit (Qiagen)
accordingtothemanufacturer’sinstructionswithon-columnDNase
I digestion. The amount of total RNA was measured using a Bio
Photometer (Eppendorf). One microgram of total RNA was used as
a templateforcDNA synthesiswith the SuperScript IIIFirst-Strand
Synthesis System (Invitrogen). The PCR reactions (20 ml) were
carried out using Taq DNA Polymerase (Invitrogen) according to
the manufacturer’s instructions. PCR conditions were: 3 min at
94uC, 30 sec denaturation at 94uC, 45 sec annealing at 55uC, and
1 min 30 sec extension at 72uC. Primers were designed based on
the mouse sequence and BLASTed for their specificity at the
National Center for Biotechnology Information (NCBI) [12].
Primer sequences are described in Table 1.
Amplified products were used to derive standard curves for
quantitative (real-time) RT-PCR. Real-time PCR was performed
in an iCycler iQ system using a SYBR green PCR master mix
(Biorad), with the following cycle conditions: an initial denatur-
ation step of 95uC for 3 min was performed, followed by 45 cycles
of denaturation at 95uC for 30 sec, annealing at 57uC for 30 sec
and extension at 72uC for 30 sec [13].
In vitro aggregate assay
Aggregatesweresampled at day15, 30, 40,50, 60 and 100. These
specimens were fixed in 4% paraformaldehyde. After dehydration in
Table 1. Primer Sequences.
Gene Primer
Sox9 For: 59-AGCTCACCAGACCCTGAGAA-39
Rev: 59-GATTCTCCAATCGTCCTCCA-39
Aggrecan For: 59-CAGGGTTCCCAGTGTTCAGT-39
Rev: 59-CTGCTCCCAGTCTCAACTCC-39
COL1 For: 59-CTGCCTGCTTCGTGTAAA-39
Rev: 59-ACGTTCAGTTGGTCAAAGGTA-39
COL2 For: 59-CCGTCATCGAGTACCGATCA-39
Rev: 59-CAGGTCAGGTCAGCCATTCA-39
COL10: For: 59-AAGGAGTGCCTGGACACAAT-39
Rev: 59-GTCGTAATGCTGCTGCCTAT-39
MMP13 For: 59-CAGTTGACAGGCTCCGAGAA-39
Rev: 59-CGTGTGCCAGAAGACCAGAA-39
Cbfa1 For: 59-CCGCACGACAACCGCACCAT-39
Rev: 59-CGCTCCGGCCCACAAATCTC-39
Osteocalcin For: 59-TCTCTCTGCTCACTCTGCTGG-39
Rev: 59-ACCGTAGATGCGTTTGTAGGC-39
b-actin For: 59-GGCCCAGAGCAAGAGAGGTATCC-39
Rev: 59-ACGCACGATTTCCCTCTCAGC-39
doi:10.1371/journal.pone.0010998.t001
Figure 1. Condensation of differentiated ESCs. (A) The morphology of ESC chondrogenic aggregates cultured at day 5 (a) and 15 (b), Alcian
Blue at day 15 (c). Scale bars represent 100 mm. (B) The ultra-structure of static suspension aggregates was analyzed by SEM on day 15 (a, b, c). (C) The
H&E histological section of chondrogenic aggregate cultured at day 15 (a), Higher magnification (b), Alcian Blue (c). Scale bars represent 20 mm. (D)
Expression of Sox9, Aggrecan, COL 2 and COL 10 mRNAs were analyzed by semi-quantitative RT-PCR at 0 (ESCs), 15 and 30 days of differentiation. b-
actin was used as an internal control. (E) GAG content was determined. Data is expressed as mean 6 SD (n=4) per well. * Significant difference from
day 0 (ESCs). P,0.05 with Student’s t-test. (F) Calcium accumulation during differentiation was determined. Data is expressed as mean 6 SD (n=4)
per well. * Significant difference from day 0 (ESCs).
# Significant difference from day 15 P,0.05 with Student’s t-test.
doi:10.1371/journal.pone.0010998.g001
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PLoS ONE | www.plosone.org 3 June 2010 | Volume 5 | Issue 6 | e10998Figure 2. Chondrocyte differentiation. (A) The ultra-structure of static suspension aggregate was analyzed by SEM at day 15. (B) The cells shed
from aggregates displayed two types, round-shaped with fibrils (a) and flat fibroblastic cells (b). Scale bars represent 20 mm. (C) The round-shaped
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embedded in paraffin. The paraffin sections were then deparaffi-
nized, hydrated, and stained with hematoxylin and eosin (H&E),
AlcianBlue(Wako),Alizarin Red S (Wako), Methylene Blue, COL 1
and COL 2 (Santa Cruz). Methylene Blue consisted of methylene
blue (Sigma) and 0.03% basic fuchsin (Sigma) [9,11]. Methylene
Blue with basic fuchsin binds to collagen [9].
In vivo implant assay
To determine chondrogenic potential in vivo, 20–30 aggregates
were injected into the femoral muscle of SCID mice, using a 25
gauge syringe. ESCs were differentiated into chondrocyte lineage
in vitro for 30 days; these aggregates were then transplanted into the
SCID mice for another 4 weeks of growth. SCID mice were
obtained from Taconic and housed in the single-barrier animal
facility of the Faculty of Medicine, University of Calgary [8]. After
4 weeks the animals were sacrificed and tissue at the point of
injection was dissected. These specimens were fixed in 4%
paraformaldehyde and decalcified in 10% EDTA (pH 8.0)
solution for 1 week. After dehydration in ascending concentrations
of ethanol and xylene, the specimens were embedded in paraffin.
The paraffin sections were then deparaffinized, hydrated, and
stained with H&E, Toluidine Blue (Wako), and Methylene Blue.
Immunofluorescence
Cells were fixed in 4% paraformaldehyde for 15 min and washed
twice with PBS-T. After permeabilization with PBS containing 0.1%
Triton-X, cells were washed twice with PBS-T, blocked with PBS
containing 3% BSA for 1 hour at room temperature, and incubated
with primary antibody (Santa Cruz, 1:200 with 3%BSA/PBS)
overnight at 4uC. The cells were washed three times with PBS-T
followed by incubation with Alexa flour 488 conjugated secondary
antibody (1:500 with PBS) and DAPI (1:500 with PBS) for 2 hours at
room temperature. Unbound secondary antibodies were removed by
three washes with PBS-T. Fluorescent images were captured using a
fluorescent microscope (IX70, Olympus, Japan) equipped with CCD
camera (RT Color, Diagnostic, Spot Software V4.0.9) [8].
TUNEL staining
To identify the apoptotic cells, TUNEL staining was performed
using the in situ cell apoptosis detection kit according to the
manufacturer’s instructions (Roche). Briefly, sections were fixed
with 4% paraformaldehyde for 30 min. Terminal deoxynucleoti-
dyl transferase (TdT) and biotin-11-dUTP reactions were
performed for 1 hour at 37uC. Fluorescent images were captured
using a fluorescent microscope equipped with CCD camera [8].
Statistical analysis
Means 6 S.E.M. were calculated and statistically significant
differences between two groups were determined using the
Student’s t-test at P,0.05 (Excel, Microsoft).
Results
Cell condensation and spontaneous scaffold formation
Following micro-mass chondrogenic differentiation, the result-
ing aggregates were cultured in static suspension (Fig. 1Aa). At day
15, these spherical aggregates showed Alcian Blue positive
staining, indicating the presence of proteoglycans in the aggregates
(Fig. 1Ab, c). Using SEM imagining, aggregates were found to
consist of many round-shaped cells with some fibrils (Fig. 1B). The
extending fibers formed networks and had the appearance of a
fibril scaffold (Fig. 1Bc). Sectioning of the aggregates revealed cells
that were tightly connected by these fibrils, resulting in uniform
and compact cell aggregate formation (Fig. 1C). Pores were not
observed during this phase of chondrogenic differentiation. These
results indicated that chondrogenic differentiation of ESCs formed
uniform and compact cell aggregates with the network of fibrils by
day 15.
Chondrocyte differentiation and its plasticity in adhesion
culture
In this study, aggregates were cultured in Petri dishes. These
aggregates showed chondrogenic potential as indicated by PCR,
GAG and calcium accumulation (Fig. 1D–F). A small population
of cells was found to be sloughed off from the surface of the cell
aggregate and attached to the Petri dish. Interestingly, both round-
shaped and fibroblastic cells were observed (Fig. 2B). Round-
shaped cells had similar fibrils to those seen in the suspension
culture aggregates (Fig. 2A, Ba, C). These fibrils connected with
each other, resulting in a network formation (Fig. 2C). These cells
were found to express the chondrocyte-related genes, Aggrecan,
collagen (COL) 2 and 10, and Sox9 based on semi-quantitative
RT-PCR (Fig. 2F). Chondrocyte related proteins, Aggrecan, COL
2, and COL 10 and proteoglycans were also found to be present
using immunoflourescence (Fig. 2D) and staining for Alcian Blue
(Fig. 2E), respectively. These results indicated that the round-
shaped cells shed from the aggregates were chondrocytes. As the
culture process progresses, these chondrocytes spontaneously
formed cartilaginous aggregates (Fig. 2E).
Extracellular matrix deposition and cartilage formation
As the culture progressed, the margins of the aggregates became
sharply defined (Fig. 3Aa). The fibrils observed previously on day
15 had disappeared, and were replaced by a smooth surface
observed on day 40 (Fig. 3Ab, c). Sectioning of aggregates on day
30 showed that extracellular matrix (ECM) was deposited around
the cells. An abundance of ECM surrounding the lacunae was also
observed on day 40 (Fig. 3B). The aggregates appeared to have
morphology similar to that found in cartilage (Fig. 3Be). These
results indicated that the cells in the aggregates change their
morphology and the fibrils were replaced with cartilaginous ECM
during long term differentiation.
Following transplantation, the aggregates formed cartilage
(Fig. 3Ca–f), as well as bone (Fig. 3Cd–i) in vivo. These results
indicated that the aggregates had the potential to continue to
proliferate and differentiate in vivo through chondrogenesis and
chondral ossification.
Hypertrophy and degradation of cartilage and
subsequent bone replacement
During further development, a dark core appeared in the centre
of aggregates by day 50 (Fig. 4A). Sectioning of these aggregates
showed the presence of hypertrophic cartilage (Fig. 4Ba). Degrad-
cells formed network spontaneously. Scale bars represent 50 mm. (D) The expression of chondrocyte-related proteins (Aggrecan, COL 2, COL 10) was
analyzed at day 20 of differentiation by immunofluorescence (a, d, g), DAPI (b, e, h), Bright field (c, f, i). Scale bars represent 50 mm. (E) Alcian Blue
stained chondrogenic cells at day 20 of differentiation (a, b). These cells were induced to form the aggregates spontaneously (c, d). Scale bars
represent 50 mm. (F) The expression of chondrocyte-related mRNAs (Sox9, Aggrecan, COL 2, COL 10) and fibroblast-related mRNA (COL 1) were
analyzed at day 20 by semi-quantitative RT-PCR. b-actin was used as a loading control.
doi:10.1371/journal.pone.0010998.g002
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(Fig. 4Bb, c, d). The degraded cartilage was also found to include
apoptotic cells as indicated by TUNEL staining (Fig. 4C). During
this phase of chondrogenesis, the amount of proteoglycans present
is decreasing with a concomitant increase in calcification (Fig. 4D).
Interestingly, high calcification was evident in the membranous
tissues replacing the cartilage as indicated by Alcian Blue staining
(Fig. 4Dd). In this way, cartilage was replaced by bone-like
membranous tissue. More regions of bone were observed by day
100 (Fig. 4E). These results indicated that hypertrophic and
degraded cartilages were formed, resulting in the aggregates
forming calcified tissue resembling bone in vitro at a later stage.
Figure 3. In vitro cartilage formation, and In vivo cartilage and bone formation. (A) The morphology and ultra-structure of aggregate
cultured at day 40. Morphology (a), Scale bars represent 100 mm. SEM (b, c) (B) The histological section of ESC chondrogenic aggregate cultured at
day 30 and 40, H&E staining (a, d). Higher magnification (b, e). Alcian Blue (c, f). COL 2 (g, h). Scale bars represent 20 mm. (C) Transplantation of
aggregates. Cells were cultured in vitro for 30 days under the chondrogenic differentiation protocol. The aggregates were then transplanted into SCID
mice. After removal of transplanted tissue, both cartilage and bone tissues were observed. Cartilage was indicated by Toluidine Blue (b, e). Bone was
indicated by Methylene Blue (f, i). Scale bars represent 50 mm.
doi:10.1371/journal.pone.0010998.g003
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suspension
We next used real time RT-PCR to examine the expression of
chondrocyte, osteoblast and other markers during suspension
culture (Fig. 5). Sox9, a chondrocyte transcription factor, which
induces the expression of cartilage matrix, was significantly up-
regulated after chondrogenic induction and peaked at day 30
(Fig. 5a). Expression of the cartilage ECM protein marker,
Aggrecan and COL 2 peaked by day 30 and decreased by day
40 (Fig. 5b, c). Based upon the expression of COL 10,
hypertrophic chondrocytes appeared within the population as
early as day 10. After down-regulation at day 20, COL 10 was
up-regulated again by day 30 and remained at moderate levels
throughout the course of the culture period (Fig. 5d). MMP13, a
protease expressed by terminal hypertrophic chondrocytes,
peaked at day 30 and up-regulated again at day 50 and 60
(Fig. 5e). Overall, the expression of chondrocyte-related genes
was up-regulated by day 30.
Cbfa1 expressed by chondrocytes was maintained through
terminal hypertrophic differentiation and induced bone formation,
Figure 4. In vitro hypertrophy and degradation of cartilage, and bone replacement. (A) The morphology of aggregate cultured at day 50.
Scale bars represent 100 mm. (B) The histological section of aggregate cultured at day 50 or 60 was stained by H&E. Hypertrophic cartilage (a),
Degraded cartilage (b), Degraded cartilage and bone replacement (c) and bone replacement (d). Scale bars represent 20 mm. (C) Apoptotic cells were
indicated by TUNEL staining. TUNEL (a), Bright field (b). Scale bars represent 20 mm. (D)The section of bone replacement cultured at day 60. H&E (a),
Alcian Blue (b), Alizarin Red S (c), Alcian Blue & Alizarin Red S (d), Methylene Blue (e). Scale bars represent 20 mm. (E) The section of bone cultured at
day 100. H&E (a), Alizarin Red S (b), COL 1 (c). Scale bars represent 20 mm.
doi:10.1371/journal.pone.0010998.g004
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(Fig. 5f). The expression of Osteocalcin a late marker of bone
ECM peaked by day 60 (Fig. 5g).
Discussion
The field of regenerative medicine promises the development of
cell-based therapies [15]. ESCs may provide a source of these cells,
due to their ability to provide large numbers of specialized cell
types via in vitro differentiation [16,17]. However, the greatest
challenge facing the use of ESCs in regenerative medicine and
tissue engineering is determining how cells respond and form tissue
during differentiation and development. The successful use of
ESC-derived cells for clinical application requires a pure cell
population, maintenance of differentiated cell phenotype and
constitution of functional tissue in vitro and in vivo [9,10,18].
Therefore, a better understanding of the developmental process
would have a significant impact on the design of strategies for
regenerative medicine using ESCs.
Chondrogenesis is the earliest phase of skeletal development.
This involves condensation of progenitors, chondrocyte differen-
tiation, and deposition of cartilaginous extracellular matrix (ECM),
resulting in the formation of cartilage and bone during
chondrogenesis [2]. In this study, we focused on understanding
the morphogenetic events during chondrogenic differentiation
of ESCs in static suspension culture. Each stage was charac
terized as an established in vitro ESC developmental process of
chondrogenesis.
As we mentioned previously, the first step in chondrogensis is
cell condensation and the subsequent formation of condensed cell
aggregates that occurs prior to chondrogenic differentiation
[19,20]. At this stage, factors such as the TGF-b superfamily
(TGF-b and BMPs) are known to play critical roles in the
compaction of progenitors cells and shaping of the condensations
[21]. The biochemical effect of growth factors in concert with
physical factors such as this micro-mass approach and self-
assembly potential of ESCs would promote spherical cell
condensation. The combination of biochemical effects, culture
environment and characteristic of ESCs helps to create cell
condensations as the cellular modules or units from which
skeletons are built.
The second stage of chondrogenesis has been associated with
changes in cell morphology and concomitant changes in gene
expression for cell fate commitment. During this stage, ESCs
differentiated into chondrocytes within spherical aggregates. In
particular, the expression of a transcriptional factor Sox9 induces
progenitor cells to become chondrocytes during cell condensations
[1,2,22]. In this study, differentiated ESCs were shown to have
Figure 5. Gene expression during chondrogenesis in suspension culture. The expression of chondrocyte and osteoblast-related genes was
analyzed from 0 to 60 days of differentiation by real-time RT-PCR. Sox9 (a), Aggrecan (b), COL 2 (c), COL 10 (d), MMP13 (e), Cbfa1 (f), Osteocalcin (g).
Data is expressed as means 6 SD (n=3) per lane. With a P,0.05 using the Student’s t-test, * represents a significant difference between two.
doi:10.1371/journal.pone.0010998.g005
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The network of fibrils served as a scaffold for further cartilaginous
deposition and cartilage formation. Under appropriate conditions,
differentiated ESCs had the potential to develop the phenotypic
features of the chondrocyte and create a suitable environment for
cartilage formation by itself.
The round-shaped cells seen in the adherent cultures had
similar characteristics of the chondrocyte such as a fibril network,
expression of proteoglycans and other chondrocyte-related
markers (Fig. 2). However, these cells showed plasticity of their
phenotypes, as both round-shaped and fibroblastic cells were
found in an adhesion culture (Fig. 2B). It has been previously
Figure 6. Schematic summary of the stages of chondrogenesis of ESCs. The relative temporal aspects of five stages of chondrogenesis are
denoted by cellular, extracellular and molecular events: (1) Condensation of differentiated ESCs, (2) Differentiation into chondrocytes and fibril
scaffold formation, (3) ECM deposition and cartilage formation, (4) Hypertrophy and degradation of cartilage, and (5) Bone replacement. Scale bars
represent 20 mm.
doi:10.1371/journal.pone.0010998.g006
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into fibroblastic cells morphologically as the culture process
progresses on a two-dimensional substrate [14]. This morpholog-
ical change has previously been associated with the loss of the
chondrocytic phenotype- [14]. Therefore, in terms of not only
producing a sufficient number of pure chondrocytes but also the
suppression of cellular dedifferentiation, it is important that the
spherical conformation be maintained in suspension culture.
These findings suggest that the culture environment is an
important factor in the regulation of differentiation of chondro-
cytes as well as stabilization of their phenotypes.
After expression of Sox9, chondrocytes synthesize cartilaginous
ECM [1,2,22]. In this study, copious amounts of ECM were
deposited, resulting in cartilage formation in vitro (Fig. 3B). Fibril
networks that were formed previously were replaced by ECM and
seemed to serve as a framework for cartilage formation. It is
noteworthy that these aggregates showed chondrogenic activity, as
cartilage formation and replacement with bone-like membranous
tissues occurred in vivo (Fig. 3C). For this reason, this system would
provide the opportunity not only to analyze the process of
chondrogenesis but also to determine the in vivo responses of
differentiated ESC when they are transplanted. This in vivo analysis
could support our in vitro observations.
During development, terminally differentiated cells withdraw
from the cell cycle, initiating the process of hypertrophic
differentiation. At this stage, chondrocytes undergo hypertrophy
and apoptosis to render hypertrophic cartilage and degradation,
respectively [23,24]. The process of chondral ossification occurs in
the development of long bones from a cartilagenous anlagen
[24,25]. In this study, hypertrophic and degraded cartilages with
bone-like membranous tissues were observed at 50 or 60 days
(Fig. 4B, C). Their residual cartilage matrix seemed to serve as a
scaffold for further calcium deposition and bone formation.
Finally, bone is deposited on remnants of the cartilage matrix
through chondral ossification [9,24]. In this study, calcified and
bone-like membranous tissues were observed at late stages in vitro
(Fig. 4D, E). Primary bone formation seemed to occur via cartilage
resorption. In previous investigations of chondral ossification,
calcification was observed within aggregates, it was thought to
require the in vivo environment with vasculogenesis from the
neighboring connective tissue [9,10,21,24–26]. Interestingly, we
could observe primary bone formation with bone-like membra-
nous tissues via cartilage resorption in vitro. However, for more
functional secondary bone formation including bone remodeling,
it will require collaboration with the haematopoetic stem cell
niche, such as vascular invasion in vivo, as has been previously
reported [26].
The relative temporal aspects of each stage of chondrogenesis
were also denoted by their associated molecular processes. After
the first appearance of chondrogenic markers (Sox9, Aggrecan,
COL 2), which decline thereafter, the hypertrophic chondrogenic
marker (COL 10) appear almost immediately with sustained
expression (Fig. 2D, 5). These cells seemed to commit to apoptosis
at day 50, as shown by TUNEL staining (Fig. 4C). The expression
of protease and osteogenic markers (MMP13 and Osteocalcin,
respectively) resulted in degraded cartilage and primarily bone
formation at day 50 and 60 (Fig. 4D).
Overall, we have demonstrated that ESCs exhibit dynamic
morphological changes encompassing chondrogenic differentia-
tion (Fig. 6). ESC chondrogenesis can be characterized by five
main stages of cellular, extracellular and molecular events: (1)
Condensation of differentiated ESCs, (2) Differentiation into
chondrocytes and fibril scaffold formation, (3) ECM deposition
and cartilage formation, (4) Hypertrophy and degradation of
cartilage, and (5) Bone replacement. At each stage, morphological
changes played an important role in further development as each
stage acts as a scaffold or template for later stages. These processes,
which would not be physically sequestered during development,
were controlled in a temporal-spatial manner.
For clinical application, it will require the appropriate scales and
timing of implants to fuse with the host tissues to recover natural
shape safely [1]. A precise knowledge of how to control
chondrogenesis would be essential for cartilage and bone tissue
engineering. However, in the in vivo environment there are still
unknown factors governing the differentiation of cells. The
microenvironment of cells in the existing tissue, immunological
responses and the hematopoetic niche all play important and
complex roles in the regeneration process. Our observation of five
overlapping stages during in vitro ESC chondrogenesis provides an
opportunity to understand processes within a controlled environ-
ment in vitro. Accordingly, a better understanding of chondrogen-
esis should benefit skeletal regenerative medicine.
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